1. Home
  2. AWRE vs ATNM Comparison

AWRE vs ATNM Comparison

Compare AWRE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$2.01

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.46

Market Cap

47.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
ATNM
Founded
1986
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
47.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AWRE
ATNM
Price
$2.01
$1.46
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
35.3K
183.1K
Earning Date
10-29-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
11.11
52 Week Low
$1.37
$1.03
52 Week High
$2.95
$2.41

Technical Indicators

Market Signals
Indicator
AWRE
ATNM
Relative Strength Index (RSI) 47.20 48.51
Support Level $1.80 $1.33
Resistance Level $2.11 $1.72
Average True Range (ATR) 0.11 0.10
MACD 0.00 -0.02
Stochastic Oscillator 65.14 30.77

Price Performance

Historical Comparison
AWRE
ATNM

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: